Breast Cancer Trial, Not Yet Recruiting NCT07415200 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07415200
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women between the ages of 18 and 75
  • People with a confirmed diagnosis of invasive breast cancer (confirmed through tissue testing)
  • People whose breast cancer has spread to the lymph nodes in the armpit, requiring surgical removal of those lymph nodes
  • People with a Body Mass Index (BMI) of 25 or higher (confirm with trial site if unsure how BMI is calculated)
  • People who are planned to receive radiation therapy to the lymph node region after surgery
  • People who are able to understand what the study involves and sign a written consent form
  • People who are willing and able to attend follow-up visits and complete study assessments

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously had surgery on the same-side armpit area
  • People who have previously had radiation therapy to the same-side armpit area
  • People whose breast cancer has spread to other parts of the body (such as bones, lungs, or liver)
  • People who have breast cancer in both breasts, or who have a history of surgery on the breast on the other side
  • People with serious liver, kidney, or heart problems
  • People who are not able to read or understand Chinese well enough to complete the study questionnaires and assessments
  • People who are pregnant
  • People with any other condition or situation that the trial doctors believe may make it difficult to participate fully in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 20 36997641

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Lymphedema-Free Survival of the Operated Arm

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov